UBS Group’s Simplify Health Care ETF PINK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.8K Buy
+202
New +$7.21K ﹤0.01% 8653
2025
Q4
Sell
-59
Closed -$1.87K 11014
2025
Q3
$1.87K Sell
59
-25,003
-100% -$756K ﹤0.01% 9266
2025
Q2
$752K Buy
25,062
+24,627
+5,661% +$708K ﹤0.01% 5685
2025
Q1
$12.8K Sell
435
-7,139
-94% -$214K ﹤0.01% 8480
2024
Q4
$225K Sell
7,574
-4,705
-38% -$148K ﹤0.01% 6382
2024
Q3
$403K Buy
+12,279
New +$396K ﹤0.01% 5381
2023
Q4
Sell
-2,491
Closed -$62.5K 9761
2023
Q3
$62.5K Buy
+2,491
New +$65.3K ﹤0.01% 6155
2023
Q2
Sell
-1,823
Closed -$45.8K 9465
2023
Q1
$45.8K Buy
+1,823
New +$46.1K ﹤0.01% 6521
2022
Q4
Sell
-2,141
Closed -$51K 11037
2022
Q3
$51K Buy
+2,141
New +$53.9K ﹤0.01% 6341
2022
Q2
Sell
-11
Closed 10772
2022
Q1
$0 Sell
11
-239
-96% -$6.18K ﹤0.01% 10740
2021
Q4
$7K Buy
+250
New +$6.58K ﹤0.01% 9160

Other funds holding PINK

UBS Group's PINK Position: Q1 2026 in Review

UBS Group opened a new position in Simplify Health Care ETF (PINK) in Q1 2026: 202 shares worth $6.8K. The stake represents ﹤0.01% of the portfolio and ranks #8653 among its holdings. This is a return to the name: UBS Group previously reported a position in PINK as recently as Q3 2025.

UBS Group first reported a position in PINK in Q4 2021 and has held it in 11 quarters since. The position peaked at $752K in Q2 2025. 61 funds tracked by Wall St. Rank hold PINK as of Q1 2026.

  • UBS Group held 202 shares of Simplify Health Care ETF worth $6.8K as of Q1 2026.
  • Simplify Health Care ETF was a new UBS Group position in Q1 2026.
  • Simplify Health Care ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8653 holding.
  • UBS Group first reported a position in Simplify Health Care ETF in Q4 2021 and has held it in 11 quarters since.
  • UBS Group's Simplify Health Care ETF position peaked at $752K in Q2 2025.
  • 61 funds tracked by Wall St. Rank held Simplify Health Care ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.